Introducing the ST8SIA3 coding sequence into low- and mild-level A2B5-expressing GBM cell lines resulted in a huge increase of A2B5 immunoreactivity and showed that the A2B5 immunoreactivity level was positively correlated with ST8SIA3 expression. This evidence concerns the gene ST8SIA3 and glioblastoma.